Hepatotoxicity - Ciprofloxacin-Induced
"Suspected Ciprofloxacin-Induced Hepatotoxicity."
Published in Hepatitis Weekly, May 8th, 1995
According to the authors' abstract of an article published in Annals of Pharmacotherapy, "Objective: To report a case of probable ciprofloxacin-induced hepatotoxicity. Case Summary: A 44-year-old woman developed severe hepatitis 3 weeks after initiation of a 7-day course of oral ciprofloxacin therapy. Liver biopsy showed severe hepatic necrosis, and other causes of liver injury were excluded. Liver function test results returned to normal 4 months after the appearance of jaundice. Discussion: The time course of events suggested that ciprofloxacin was the cause of severe hepatitis in this patient, and other causes of hepatitis were ruled out. Hepatotoxicity...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (1995-05-08)
More Articles from Hepatitis Weekly
- Biotechnology
Transgenic Plants Produce Immunogenic Hepatitis B Antigen - Conference Coverage
DNA-Mediated Immunization to HBV May Be Useful - Conference Coverage
DNA Immunization Offers Safety in Those Who Are Immunocompromised - Conference Coverage
Despite HBV Vaccine, Transmission Problems Persist - Conference Coverage
HCV Genotypes Have Important Clinical Implications - Conference Coverage
HEV Infection Poses Threat to Pregnant Women in Endemic Areas - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
